Sonexa Therapeutics, Inc., a pharmaceutical company, engages in the development of therapeutics drugs for the treatment of Alzheimer's disease and related disorders. It develops ST101, a small and orally active molecule compound that penetrates the blood-brain-barrier. The company was incorporated in 2007 and is based in San Diego, California.
Funding Rounds (5) - $41.2MUpdate
As a wholly owned subsidiary of Mitsubishi Corporation, Mitsubishi International Corporation...
The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in...
Alta Partners is a leading venture capital firm in life sciences, funding over 130 companies in...
Scale Venture Partners invests in early-in-revenue technology companies involved in SaaS-based,...
Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on...
12481 High Bluff Drive
San Diego, CA 92130